Federal and state governments' latest strategy in the fight to rein in the power of pharmacy benefit managers (PBMs) is ...

The authors concluded that the combination of supplements containing silicon dioxide, along with dietary and fluid restriction during Ramadan, likely increased the patient's risk for developing a ...

In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how clinicians can communicate effectively and empathetically with patients ...

Diet adherence also tended to be associated with lower risks of cause-specific mortalities, including cardiovascular, neurodegenerative, and respiratory diseases, as well as cancer, Liangkai Chen, PhD ...

The Trump administration on Thursday revoked a scientific finding that climate change is a danger to public health, an idea ...

Previous exposure to ibrutinib (Imbruvica) among patients with mantle cell lymphoma (MCL) was associated with improved efficacy after treatment with the chimeric antigen receptor (CAR) T-cell therapy ...

The move to ease the restrictions was backed by The Menopause Society (TMS), which said the boxed warning "may have been a deterrent to the use of the low-dose vaginal estrogen, which is a safe and ...

A first-of-its-kind clinical trial will compare the investigational chimeric antigen receptor (CAR) T-cell therapy rondecabtagene autoleucel (ronde-cel) against physician's choice of approved CAR ...

Among the more than half of practices surveyed that lost a physician to burnout in the last 3 years, three-quarters said "regulatory burden" played a role, said Jeffrey Smith, MBA, of the Medical ...

FDA vaccine chief Vinay Prasad, MD, MPH, who made the controversial decision to refuse to review Moderna's mRNA flu vaccine, has been accused of sexual harassment and berating staff. ( BioSpace) ...

Since Robert F. Kennedy Jr. was sworn in to lead HHS 1 year ago, he has defended his upending of federal health policy by saying the changes will restore trust in America's public health agencies.

The emergence of expert panels at the FDA -- different from true advisory committees -- raises questions regarding their lawfulness and credibility in relation to agency decisions, according to a ...